The results in our study displayed that high expression of PER3 were associated with essential immune cells or biomarkers like T cells CD4 + , T cells CD8 + and PD-L1, which providing a novel strategy to treat HNSCC patients. The gene discussed is PER3; the disease is head and neck squamous cell carcinoma.